๐Ÿ“–
SGLT2 inhibitor therapy following aortic valve intervention for aortic stenosis: a systematic review and meta-analysis of mortality, heart failure, rhythm, renal, and valve-related outcomes.
Megantara HP, Dakota I, Taofan T, Indrian S, Aurora RG, Adiarto S

SGLT2 inhibitor therapy following aortic valve intervention for aortic stenosis: a systematic review and meta-analysis of mortality, heart failure, rhythm, renal, and valve-related outcomes.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in J Cardiothorac Surg.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title SGLT2 inhibitor therapy following aortic valve intervention for aortic stenosis: a systematic review and meta-analysis of mortality, heart failure, rhythm, renal, and valve-related outcomes.
Author / Organization Megantara HP, Dakota I, Taofan T, Indrian S, Aurora RG, Adiarto S
Subject & Discipline J Cardiothorac Surg
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-33698
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »